Top 5 Takeaways Immunocompromised patients represented a significant portion of COVID-19 hospitalizations. Accounting for 12.2% of adult COVID-19 hospitalizations across 10 states, immunocompromised patients had increased odds of ICU admission
Tag: MMWR Boosters
Top 5 Takeaways Identification of the Outbreak: On January 14, 2022, two inmates at a Nebraska correctional facility were diagnosed with Salmonella Enteritidis, prompting an investigation that linked the outbreak
Top 5 Takeaways Significant Testing Capacity and Results: The Laboratory Response Network (LRN) tested 2,009 specimens for monkeypox, identifying 730 (36.3%) positive cases from 395 patients, with 159 confirmed by
Top 5 Takeaways Expansion of Laboratory Testing: In December 2016, the Minnesota Department of Health expanded laboratory testing for varicella, showing that among 208 patients with a clinical diagnosis, 45%
Top 5 Takeaways Significant Scale-Up in TB Preventive Treatment: From October 2016 to October 2023, about 13 million ART clients completed Tuberculosis Preventive Treatment (TPT) across 36 countries supported by
Top 5 Takeaways Case Counts Fluctuated During the Pandemic: Coccidioidomycosis and histoplasmosis case counts dropped in 2020 compared to 2019, but saw an increase in 2021. A notable high blastomycosis
Top 5 Takeaways Reduced Reactions Post-Booster: Immunocompromised individuals aged ≥12 years reported fewer local and systemic reactions after the fourth dose (mRNA booster) compared to after the third dose of
Top 5 Takeaways Significant Decrease in HIV Testing and Case Identification: The first months of the COVID-19 pandemic saw a 40.1% decrease in HIV testing and a 29.4% decrease in
Top 5 Takeaways Disproportionate Increases Among Black and AI/AN Persons: From 2019 to 2020, overdose death rates soared by 44% for Black individuals and by 39% for AI/AN individuals, compared
Top 5 Takeaways Variability in Case Definitions: The report highlights the significant variation in toxoplasmosis case definitions across six states, affecting disease estimates and comparisons. Challenges in Surveillance: Identifying newly